Lab
Laboratorio Clinico Roxell INC
Laboratorio Clinico Roxell INC was paid $1.91M by Medicaid between Jan 2018 and Dec 2024, across 34 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 34% of everything it billed.
33Billing provider infoLABORATORIO CLINICO ROXELL INC
HUMACAO, PR 00791
HUMACAO, PR 00791
33aNPI1558339366assigned 03/08/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.91M
24GClaims87,626
24DCodes billed34
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#54 of 777
Median peer was paid$278K
This provider vs. median6.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,433 | $26K | |
| 2019 | 3,739 | $29K | |
| 2020 | 11,572 | $187K | |
| 2021 | 27,568 | $710K | |
| 2022 | 26,319 | $755K | |
| 2023 | 9,085 | $124K | |
| 2024incomplete | 5,910 | $75K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 34% | 15,422 | 13,412 | $645K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 25% | 19,824 | 16,971 | $478K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 5,023 | 4,633 | $252K |
| 86328 | 9.1% | 8,915 | 5,491 | $174K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3.3% | 3,923 | 3,534 | $63K |
| 80061 | Lipid panel | 2.7% | 3,942 | 3,532 | $51K |
| 80053 | Comprehensive metabolic panel | 2.2% | 4,109 | 3,703 | $42K |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 5,138 | 4,619 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 6,365 | 5,719 | $41K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.3% | 1,028 | 966 | $25K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 2,354 | 2,111 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,546 | 1,167 | $17K |
22 more codes
| 81000 | <1% | 4,692 | $15K | |
| 86738 | <1% | 1,074 | $12K | |
| 84439 | <1% | 725 | $6K | |
| 82274 | <1% | 440 | $6K | |
| 86701 | <1% | 391 | $3K | |
| 82043 | <1% | 622 | $3K | |
| 87088 | <1% | 325 | $3K | |
| 86592 | <1% | 620 | $2K | |
| 84436 | <1% | 395 | $2K | |
| 82607 | <1% | 145 | $2K | |
| 84479 | <1% | 312 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 12 | $615.96 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 17 | $576.15 |
| 82570 | <1% | 87 | $450.04 | |
| 86702 | <1% | 29 | $300.90 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 46 | $250.04 |
| 87275 | <1% | 20 | $195.41 | |
| 87276 | <1% | 19 | $191.28 | |
| 86706 | <1% | 12 | $121.88 | |
| 87070 | <1% | 13 | $104.26 | |
| 85651 | <1% | 29 | $83.08 | |
| 86140 | <1% | 12 | $28.15 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBORECKI, MARY ANN (DIRECTOR)